Introduction: Potentially preventable hospitalisation (PPH) has been adopted widely by international health systems as an indicator of the accessibility and overall effectiveness of primary care. The Assessing Preventable Hospitalisation InDicators (APHID) study will validate PPH as a measure of health system performance in Australia and Scotland. APHID will be the first large-scale study internationally to explore longitudinal relationships between primary care and PPH using detailed person-level information about health risk factors, health status and health service use.
InDicators (APHID) study
• APHID will validate potentially preventable hospitalisations (PPH) as a measure of health system performance in Australia and Scotland
• APHID will create a new longitudinal data resource by linking together detailed data from a large-scale cohort study and prospective administrative data relating to use of health services
Key messages
• PPH have been adopted widely by international health systems as an indicator of the accessibility and overall effectiveness of primary care
• However, much of the existing evidence is based on ecological (aggregate)
analyses, and comes from the United States
• Key questions about the validity and value of PPH measures, and their applicability in different settings, remain unanswered
Strengths and limitations of this study
• APHID will be the first large-scale study internationally to explore longitudinal relationships between primary care and PPH using detailed person-level information about health risk factors, health status and health service use
• Limitations include the use of administrative claims data containing only limited information about the quality of primary care services, and reliance on self-reported data for some predictor variables. hospitalisations' and 'preventable hospitalisations') are those that could potentially be prevented by timely and effective provision of primary care [1] . The concept of PPHs was originally developed in the United States of America (USA) [1] [2] [3] [4] , but has been adopted widely by international health systems as an indicator of the accessibility and overall effectiveness of primary care (e.g. [5] [6] [7] [8] ). In Australia, rates of PPH for selected conditions are a key performance indicator specified in the National
Healthcare Agreement (NHA) [9, 10] , which is intended to track progress against the objective 'Australians receive appropriate high quality and affordable primary and community health services'. The conditions that are currently included in the NHA indicator are shown in Table 1 [10] . These are based on the Victorian ACSC study [11] , which in turn had its origins in work in the USA in the 1990s [1] [2] [3] that used physician expert panels to identify and rank candidate conditions. However, there is considerable variation in the PPH condition sets that are used across countries, and for PPH measures are particularly attractive as indicators of health system performance because they can be generated from routine hospital data and yet focus attention on the outcomes of care, rather than process or throughput. However, a number of key questions about the validity and value of these measures remain unanswered. Much of the research relating to PPHs has focussed on socioeconomic, race and urban-rural differentials, which may reflect gradients in health status (disease prevalence and severity) as well as in access to or quality of health care. However, studies in the USA, mainly using ecological (correlational) approaches (i.e. the unit of analysis was an aggregate of individuals, usually the population of a geographic area), have also focused on the association between PPHs and the nature of the health care system, reporting that self-reported access to medical care [12] , increased physician supply [13] [14] [15] [16] [17] [18] and presence of community health centres and rural health centres [19] [20] [21] are inversely correlated with PPH rates, while high rates of emergency department (ED) attendances are positively associated with PPH rates [21] .
Evidence from other settings is sparse. A recent study in the United Kingdom (UK), limited to chronic obstructive pulmonary disease (COPD) and using an ecological 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y design, found that patient-reported access to consultation within two days, and primary care staffing, were protective for admission rates [22] . The only Australian study to date [23] , again using ecological methods, found that access to medical care and rate of general practitioner (GP) visits (both self-reported) and GP supply were negatively associated with PPH rates in Primary Care Partnership areas in the state of Victoria, independent of disease prevalence. However, these associations disappeared when rural residence was taken into account. the different levels that may influence outcomes means that we will avoid the risk of the ecological fallacy common in ecological studies [24] .
Our specific objectives are:
1. To link questionnaire data from 267,000 participants in the 45 and Up Study to prospective data on use of primary care services, ED presentations, hospitalisations and deaths.
2. To analyse these linked data to establish the relationships between use of primary care services and measures of PPH, and the contributions of person-, geographicand service-level factors to these relationships.
3. To analyse these linked data to establish the relationship between PPH and health outcomes for people with chronic conditions, and the contributions of person-, geographic-and service-level factors to these relationships.
4. To conduct comparative analyses using data from the Scottish Morbidity Records.
5. To consider, synthesise and effectively communicate these findings in order to drive change.
Methods and analysis

Data sources
The 45 and Up Study [25] is a cohort study of 267,000 men and women aged 45
years and over and resident in New South Wales (NSW), Australia's largest state.
Briefly, participants were randomly sampled from the Medicare Australia database Data captured in the 45 and Up Study baseline and follow-up questionnaires include the following self-reported chronic conditions that are relevant to PPH: (ever diagnosed) heart disease, high blood pressure, diabetes and asthma; and (treated in the last month) 'other' heart conditions, high blood pressure and asthma. Additional data coded from free text fields allow identification of participants who reported angina, congestive heart failure and chronic obstructive pulmonary disease.
Questionnaire data also include information on key potential confounders and mediating factors, including age, sex, household income, level of education, smoking history, alcohol use, physical activity (Active Australia questionnaire) [26] , height and weight, functional status (Medical Outcomes Study Physical Functioning scale) [27] , psychological distress (Kessler 10 scale) [28] and medical and surgical history.
The NSW Admitted Patient Data Collection (APDC) will be used to identify PPH admissions and to provide information for risk-adjustment (co-morbidities, previous admissions). The APDC includes records for all separations (discharges, transfers and deaths) from all NSW public and private sector hospitals and day procedure centres.
The information reported includes patient demographics, source of referral to the [29] . Audits have shown good-to-excellent coding of diagnoses and procedures in Australian hospital data [30] . Because the APDC contains information on episodes of care (ending with the discharge, transfer, or death of a patient), rather than periods of stay in hospital, a continuous period of stay will be constructed by combining all contiguous episodes of care, including nested and non-nested transfers, for the same patient.
The Most non-hospital medical care in Australia is provided on a fee for service basis, paid by the universal health insurance scheme, Medicare, according to the Medical Up Study to the other databases that will be used in this study on an ongoing basis.
The CHeReL uses probabilistic record linkage techniques to link personal identifiers (including full name, date of birth, sex and address) from records in these datasets.
Evaluation of the accuracy of the linkage is determined by clerical review of samples of matched records. Quality assurance data show false positive and negative rates of 0.4% and <0.1%, respectively. The CHeReL uses the 'best practice protocol' [31] for preserving individual privacy. The data custodians will supply de-identified datasets for each of the data sources to the researchers, who will then merge the records together using a unique identifier.
The linked data will include all records available from July 2000 onwards for each
dataset. This will provide retrospective data for risk-adjustment, as well as prospective data for ascertainment of incident events.
Analysis plan
To establish the relationships between use of Medicare-funded services and measures of PPH (Objective 2), a series of multilevel models will be built using prospective data for all participants in the 45 and Up Study. Follow-up will be to the end of the period for which APDC data are available (December 2011), or death, whichever comes first, giving a duration of follow up from 2 to 4 years depending on the date of recruitment into the 45 and Up Study. Model building will be an iterative process and models will have up to six levels: individuals (n=267,000), GP providers (n=14,500), Analyses to explore the relationship between PPH and health outcomes for people with chronic conditions (Objective 3) will be restricted to 45 and Up Study participants who self-reported chronic PPH conditions (asthma, angina, congestive heart failure, chronic obstructive pulmonary disease, diabetes, hypertension) at baseline. They will compare outcomes for people with these conditions who have PPH episodes during follow-up with those who do not. Analyses will be performed for all of the chronic conditions as a group and stratified according to individual condition, where numbers support this. Again, a series of multilevel models will be built, with up to six levels: individuals (n=126,000), GP providers (n=14,000), Medicare Locals (n=20); SLAs (n=250), hospitals (n=400) and LHDs (n=18).
Outcome measures related to PPH will include: time to first PPH episode; number of PPH episodes; total PPH inpatient bed days; average length of PPH hospital stay; estimated costs of PPH episodes to the health system and the individual. Hospital costs will be estimated using Australian Refined Diagnosis Related Group (AR-DRG) costs obtained from national public and private sector cost data [32] . Costs to the individual will be estimated using information on labour force status and household income. Analyses will be performed for all causes and stratified according to vaccinepreventable, chronic and acute PPH, and individual PPH diagnoses where numbers support this. population; rates of unemployment and labour force participation.
Hospital-level predictor variables will include: accessibility (ARIA+) [33] ; number of beds; peer group; number of admissions (emergency, planned, medical surgical); measures of casemix; patient experience survey data; measures of hospital workforce.
LHD-level predictor variables will include: number of hospitals and communitybased services; measures of LHD workforce.
Statistical analysis will be performed using MLwiN [36] and SAS [37] . Crossclassified multilevel models will be used to account for the non-nested hierarchies of, for example, GP provider, the hospital attended and the SLA of residence [38] and will be estimated using Markov Chain Monte Carlo methods in MLwiN. Time to first PPH episode will be modelled using multilevel Cox (proportional hazards) regression analysis. All other outcomes will be modelled using multilevel Poisson regression, applying transformations to continuous variables as appropriate. All models will be corrected for possible overdispersion, either by using an adjustment parameter in the Poisson model or by fitting a negative binomial regression model. In the case of a highly right skewed distribution of the number of admissions beyond the first, zeroinflated Poisson or multinomial models will be fitted. For all models, squared and cubed terms of continuous predictor variables will be tested to improve the model fit.
A method of fractional polynomials for continuous predictor variables will be used where appropriate. Table 2 gives information on the projected numbers of PPH episodes, and persons experiencing PPH episodes, that will be available for analysis, based on linked data for the 45 and Up Study to date, and taking into account delays in the availability of data. Around 950,000 person-years of follow-up will be available for analysis. With the sample size available, we will be able to estimate average length of stay and inpatient costs, respectively, with a precision of 0.7 days and $650 for low-prevalence PPH conditions (e.g. rheumatic heart disease, pelvic inflammatory disease); 0.3 days and $275 for mid-prevalence PPH (asthma, influenza, cellulitis); and 0.07 and $65 for high-prevalence PPH (diabetes complications). Table 3 presents minimum detectable ratios for comparisons of mean length of stay and hospital costs for people with self-reported chronic conditions who do and do not have a PPH episode during follow-up (Objective 3). The power of the study will be monitored during the model-building process, using sample size calculators specifically developed for multilevel models (PinT) [39] . These require estimates of variances and covariances for predictor variables and random effects that are not available from the literature. 
Comparative analyses using Scottish hospital data
It is intended to undertake comparative analysis using Scottish data. This part of the project is at earlier stage of development and the detailed research is still subject to funding and approval. Scotland offers an interesting comparator to Australia. Both countries contain large areas that are remote and inaccessible: 6% of the Scottish population live on areas classified as remote and rural while in Australia 10% live in areas classified as remote or very remote [40, 41] . Both countries face the challenges of providing health care in these areas. However, while in Australia health is poorer in rural areas than in urban areas, in Scotland the opposite holds [42] and this is also true for deprivation [41, 43, 44] . Comparative analysis offers the prospect of GP supply has been reported to be negatively associated with PPH rates in Australia [11] . Scotland has considerably fewer GPs per 100,000 population than does Australia: 81 [45] and 110 [46] respectively. Patients are registered with a specific practice in Scotland but not in Australia, and this may significantly alter organisational approaches to preventative health care. A further difference between the two countries is the funding of health care: in Australia 45% [47] of the population holds private health insurance, compared with only 11% [48] of the Scottish population.
Scottish morbidity records will be used to identify rates of potentially preventable hospitalisations across Scotland. Factors to be explored include quality of primary care, the availability of primary and secondary care, the rurality and remoteness of the population, the degree of deprivation and population characteristics including age, gender and ethnicity. The empirical strategy outlined above to analyse the Australian data will be employed and comparative analysis will be undertaken. Wherever possible, this will employ a common specification in order to distinguish the differential impact of the factors and the extent to which these might be explained by differences in underlying population behaviours and health delivery systems.
A strength of the Scottish analysis is that relatively robust measures of the quality of primary care can be constructed. In 2004 the Quality and Outcome Framework (QOF) was introduced to incentivise the quality of care provided by general practices. 
Ethics and dissemination
Participants have consented to use of their questionnaire data and to data linkage. Dissemination mechanisms include engagement of policy stakeholders through a reference group and policy forum, which will use deliberative dialogue [50] approaches, with the goal being to identify potential actions and key implementation considerations.
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